Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (8149)	12/30/1998 10:34:00 AM
From: aknahow	Read Replies (3) \| Respond to of 17367

This fits with my concept on the difficulty of doing mega mergers in the pharmaceutical area as opposed to the natural resource area. Don't remember if I ever posted my thoughts on this or self censored them as just more unnecessary babble. >> Bayer planning mid-sized acquisitions German pharmaceutical and chemicals group Bayer is interested in acquiring more small and medium-sized pharmaceutical companies, rather than getting involved in the industry's merger merry-go-round ... [Marketletter, 137 words]